Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.
Samonakis
Dimitrios N
DN
Christodoulakis
Nikolaos
N
Kouroumalis
Elias A
EA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D018450:Disease Progression; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D015282:Octreotide / Q000627:therapeutic use*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide